Stock
Aspira Pathlab & Diagnostics Limited
Healthcare Service Provider
Share price
₹100
Market cap
₹129 Cr
1Y return
▲ 60%
Aspira Pathlab & Diagnostics Limited is a Mumbai-based pathology and diagnostic healthcare services company established in 1973. It operates multiple diagnostic centers offering pathology tests, sonography, X-ray, 2D echocardiography, and specialized health screening packages. The company holds NABL accreditation and positions itself with over 50 years of experience in diagnostic services. It is listed on the BSE (code 540788) and serves patients through in-center and home-based blood collection services across India.
Latest move
A whaleIncreased
Promoter RAJ ARVIND BHANUSHALI bought 53,970 shares of Aspira Pathlab & Diagnostics for ₹0.67 Cr at ₹125.00 apiece through an open market transaction on June 8, 2026, increasing their stake from 0.76% to 6.97% and crossing the 5% disclosure threshold.
Sign in to read more
Whales made 14 more moves in Aspira Pathlab & Diagnostics Limited
Sign in to see who is buying and selling.
Sign in to find out